Can We Find The Right Stock Using Our Newly Found Insight?

Panel Of Zacks Experts Published on July 17, 2019

Join Erique and Danny as they dive into another batch of stocks. They revisit their stock choices from Monday's episode and their conversation with Kevin Matras. They then dive into 2 new stocks using their newly taught analytic skills to see if they can find the right stock for their portfolio's. Recap on: Square: SQ, Calloway Golf: ELY, Alternative Harvest: MJ and Take Two Interactive: TTWO. New stocks of conversation: CRISPR Therapeutics: CRSP & Under Armour: UAA.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.